(Q73407410)
Statements
Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report (English)
A A Martinez
I Pataki
G Edmundson
E Sebastian
D Brabbins